共 104 条
[1]
Abou-Alfa GK(2019)ClarIDHy: a global, phase III, randomized, double-blind study of ivosidenib (IVO) vs placebo in patients with advanced cholangiocarcinoma (CC) with an isocitrate dehydrogenase 1 (IDH1) mutation [abstract LBA10_PR] ESMO 30 v872-v873
[2]
Macarulla Mercade T(2018)The sbrt database initiative of the German society for radiation oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases BMC Cancer 18 283-232
[3]
Javle M(2012)Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma Radiat Oncol 7 67-256
[4]
Andratschke N(2015)Best practice & research clinical gastroenterology epidemiology of cholangiocarcinoma Best Pract Res Clin Gastroenterol 29 221-28
[5]
Alheid H(2016)Stereotactic Body Radiotherapy for Oligometastasis: Opportunities for Biology to Guide Clinical Management Cancer J 22 247-4386
[6]
Allgäuer M(2017)Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery Cancer Res Treat 49 20-600
[7]
Barney BM(2018)The efficacy of stereotactic body radiation therapy and the impact of systemic treatments in oligometastatic patients from prostate cancer Cancer Med 7 4379-1682
[8]
Olivier KR(1996)Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer Ann Oncol 7 593-1263
[9]
Miller RC(2016)Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study Lancet Oncol 17 1672-1700
[10]
Haddock MG(2007)Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications World J Surg 31 1256-169